
Novartis' malaria drug for babies wins world-first approval
Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are infected with malaria. Switzerland’s health regulator has signed off on Coartem Baby for infants who weigh between 2 and 5 kilograms …